Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas

Pathology International

Volumn 54, Issue 8, 2004, Pages 556-563

  Mikami, Shuji ^a   Ohashi, Kenichi ^c   Katsube, Ken Ichi ^d   Nemoto, Tetsuo ^e   Nakajima, Motowo ^f   Okada, Yasunori ^b  

^a Tokyo Medical and Dental University   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^f ANB Tsukuba Institute   (Japan)

Author keywords

Angiogenesis; bFGF; Esophageal cancer; Heparanase; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEPARANASE; MESSENGER RNA; VASCULOTROPIN;

ADULT; ADVENTITIA; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CARCINOMA CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; ESOPHAGUS CARCINOMA; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LYMPH NODE METASTASIS; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; STAINING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GLUCURONIDASE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROCIRCULATION; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4344658831     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2004.01664.x     Document Type: Article

References (25)

1. Bernfield M, Gotte M, Park PW et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729-77.
2. Nakajima M, Irimura T, Di Ferrante D, Di Ferrante N, Nicolson GL. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 1983; 220: 611-13.
3. Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res 1983; 43: 2704-11.
4. Toyoshima M, Nakajima M. Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 1999; 274: 24 153-60.
5. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 1999; 5: 803-9.
6. Vlodavsky I, Friedmann Y, Elkin M et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999; 5: 793-802.
7. El-Assal O, Yamanoi A, Ono T, Kohno H, Nagasue N. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma. Clin Cancer Res 2001; 7: 1299-305.
8. Friedmann Y, Vlodavsky I, Aingorn H et al. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma: evidence for its role in colonic tumorigenesis. Am J Pathol 2000; 157: 1167-75.
9. Gohji K, Hirano H, Okamoto M et al. Expression of three extracellular matrix degradative enzymes in bladder cancer. Int J Cancer 2001; 95: 295-301.
10. Mikami S, Ohashi K, Usui Y et al. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res 2001; 92: 1062-73.
11. Elkin M, Ilan N, Ischai-Michaeli R et al. Heparanase as mediators of angiogenesis: mode of action. FASEB J 2001; 15: 1661-3.
12. Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press, 2000; 9-16.
13. Fleming ID, ed. AJCC Cancer Staging Manual, 5th edn. Philadelphia: Lippincott, 1997.
14. Saeki H, Kuwano H, Kawaguchi H et al. Expression of ets-1 transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus. Cancer 2000; 89: 1670-76.
15. Eccles SA. Heparanase: breaking down barriers in tumors. Nat Med 1999; 5: 735-6.
16. Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003; 22: 145-52.
17. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in the metastasis. J Natl Cancer Inst 1997; 89: 1260-70.
18. Inoue H, Mimori K, Utsunomiya T et al. Heparanase expression in clinical digestive malignancies. Oncol Rep 2001; 8: 539-42.
19. Ikeguchi M, Fukuda K, Yamaguchi K, Kondo A, Tsujitani S, Kaibara N. Quantitative analysis of heparanase gene expression in esophageal squamous cell carcinoma. Ann Surg Oncol 2003; 10: 297-304.
20. Naparstek Y, Cohen IR, Fuks Z, Vlodavsky I. Activated T lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase. Nature 1984; 310: 241-4.
21. Vlodavsky I, Goldshmidt O, Zcharia E et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Seminars Cancer Biol 2002; 12: 121-9.
22. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix bound VEGF. Mol Biol Cell 1993; 4: 1317-26.
23. Lu WC, Liu YN, Kang BB, Chen JH. Trans-activation of heparanase promoter by ETS transcription factors. Oncogene 2003; 22: 919-23.
24. Jiang P, Kumar A, Parrillo JE et al. Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J Biol Chem 2002; 277: 8989-98.
25. Valter MM, Hugel A, Huang HJ et al. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 1999; 59: 5608-14.